Harbour Investments’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45K | Sell |
702
-16
| -2% | -$1.03K | ﹤0.01% | 1884 |
|
|
2025
Q1 | $45.6K | Hold |
718
| – | – | ﹤0.01% | 1813 |
|
|
2024
Q4 | $47.8K | Sell |
718
-95
| -12% | -$6.32K | ﹤0.01% | 1737 |
|
|
2024
Q3 | $56.8K | Hold |
813
| – | – | ﹤0.01% | 1595 |
|
|
2024
Q2 | $52.7K | Hold |
813
| – | – | ﹤0.01% | 1527 |
|
|
2024
Q1 | $52.6K | Buy |
813
+425
| +110% | +$27.5K | ﹤0.01% | 1503 |
|
|
2023
Q4 | $25.5K | Buy |
388
+234
| +152% | +$15.4K | ﹤0.01% | 1755 |
|
|
2023
Q3 | $8.79K | Buy |
154
+58
| +60% | +$3.31K | ﹤0.01% | 2080 |
|
|
2023
Q2 | $5.89K | Sell |
96
-50
| -34% | -$3.07K | ﹤0.01% | 2225 |
|
|
2023
Q1 | $9.16K | Hold |
146
| – | – | ﹤0.01% | 2040 |
|
|
2022
Q4 | $9.27K | Hold |
146
| – | – | ﹤0.01% | 1986 |
|
|
2022
Q3 | $8K | Hold |
146
| – | – | ﹤0.01% | 2031 |
|
|
2022
Q2 | $8K | Buy |
+146
| New | +$8K | ﹤0.01% | 2031 |
|
|
2021
Q4 | $10K | Buy |
146
+96
| +192% | +$6.58K | ﹤0.01% | 1932 |
|
|
2021
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 3087 |
|
|
2021
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 3156 |
|
|
2021
Q1 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 3002 |
|